Seroconversions in unvaccinated infants: Further evidence for subclinical measles from vaccine trials in Niakhar, Senegal

International Journal of Epidemiology

Volumn 28, Issue 1, 1999, Pages 147-151

  Bennett, John ^a,b   Whittle, Hilton ^c   Samb, Badara ^d   Cisse, Badara ^e   Simondon, Francois ^f   Aaby, Peter ^g  

^a CARTER CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d INSERM   (France)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^f Fr Inst Sci Res Devmt in Coop   (France)

^g DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

Author keywords

Infants; Measles; Seroconversions; Subclinical

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE; PLACEBO;

DISEASE CONTROL; MEASLES; VACCINATION;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; MEASLES; MORTALITY; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENEGAL; SEROCONVERSION; SEX DIFFERENCE; VACCINATION;

ANALYSIS OF VARIANCE; ANTIBODIES, VIRAL; ENDEMIC DISEASES; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; MEASLES; MEASLES VACCINE; ODDS RATIO; PROSPECTIVE STUDIES; SENEGAL;

SENEGAL;

EID: 0033051694     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.1.147     Document Type: Article

References (15)

1. Whittle H, Aaby P, Samh B et al. The importance of subclinical measles in maintaining immunity in vaccinated children in West Africa. In press, 1998.
2. Chen R, Markowitz L, Albrecht P et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162:1036-62.
3. Bin D, Zhihiu C, Qichang L et al. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Organ 1991; 69:415-23.
4. Aaby P, Samb B, Simondon F et al. Sex specific mortality after high titre measles vaccines in rural Senegal. Bull World Health Organ 1994;72:761-70.
5. Whittle H, Mann G, Eccles M et al. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet 1988;i:963-66.
6. Whittle H, Campbell H, Rakman S et al. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine. Lancet 1990;336:1046-48.
7. Dean A, Dean J. Burton A et al. Epi Info, Version 6.0: A Word Processing, Database and Statistics Program for Epidemiology on Microcomputers. Centers tor Disease Control and Prevention, Atlanta, Georgia, 1994.
8. Dallal G. LOGISTIC: A logistic regression program for the IBM PC. Am Statistician 1988;42:272.
9. Krugman S, Giles J, Friedman H et al. Studies on immunity to measles. J Pediatrics 1965;66:471-88.
10. Aaby P, Bukh J, Hoff G et al. High measles mortality in infancy related to intensity of exposure. J Pediatrics 1986;109:40-44.
11. Halsey N, Boulos R, Mode F et al. Response to measles vaccine in Haitian infants 6 to 12 months old. N Engl J Med 1985;313:544-49.
12. Bellanti J, Sanga R, Klutinis B et al. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med 1969;280:628-33.
13. Kress S, Schluederberg A, Hornick R et al. Studies with live attenuated measles-virus vaccine. Am. J Dis Child 1961;101:57-64.
14. Kempe C, Ott W, St. Vincent L et al. Studies on an attenuated measles virus vaccine: III clinical and antigenic effects of vaccine in institutionalized children. A Engl J Med 1960;263:162-65.
15. Samb B, Aaby P, Whittle H et al. Serologic status and measles attack rates among vaccinated and unvaccinatcd children in rural Senegal. Pediatr Infect Dis J 1995;14:203-09.